Mach7 Technologies Limited (M7T) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning, everyone, and welcome to the Mark 7 FY25 result briefing. My name is Françoise Dixon, and I'm Head of Investor Relations for Mark 7. Today, our CEO, Terry Thomas, will provide an overview of our FY25 result. We will then open it up for questions, which will be answered by Terry and our CFO, Diana Hearn. If you have a question, please submit it by the Q&A text box at the bottom of the screen. I'll now hand over to Terri. Thank you, Francoise. All right, next slide. For those of you who don't know who we are, Mach7 is an imaging-focused vendor. We provide advanced data management and diagnostic viewing solutions to healthcare organizations all over the world. We quite love that we do something that improves healthcare. Next slide. Here's our agenda. So I'm gonna give a business overview. We're gonna go into our fiscal year 25 results. We'll talk a little bit about Outlook and then we'll have some time for Q&A. Next slide. All right, diving right into our business overview. So first of all, the foundation of this slide is we have a strong financial position and we have no debt. That was important to me even when I took this job. So as I look at assessing the business, long-term profitable growth is a big driver for me. And this slide gives you four of the areas where we've actioned already in the business. First of all, leadership renewal, me coming into this space as the CEO, but I'm also making changes in our leadership teams in terms of individual people, but also how we engage with each other, bringing some fresh skills in, some fresh perspectives, new expectations. A big part of that is a very customer centric approach to the entire business. We've overhauled our customer designated team. So how we assign our staff and how our staff engage with custom...